#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypotransferrinaemia Ichthyosis Small intestine leiomyosarcoma Acute respiratory distress syndrome Marginal zone lymphoma Antisynthetase syndrome Gastric cancer Inflammatory myofibroblastic tumour Proteus syndrome Cluster headache Peritoneal mesothelioma malignant Cerebellar ataxia Penile cancer Iron overload Congenital aplastic anaemia More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Basic Information Leiomyosarcoma recurrent – Basic Information Lennox-Gastaut syndrome Retinoblastoma – Trials in Disease IgA nephropathy Amyotrophic lateral sclerosis – Basic Information Primary hyperoxaluria – Basic Information Carcinoid syndrome – Diagnostics Hairy cell leukaemia – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adenosine Dacomitinib Sotrovimab Etamsylate Insulin Icodec Cocarboxylase Tetrahydrate Dasatinib Cannabidiol Midomafetamine Hydrochloride Nido-361 Lorlatinib Carbamazepine (Ph. Eur.) Selumetinib Decitabine Povorcitinib Bay 3283142 Ambrisentan Lisaftoclax Simoctocog Alfa ASP2957 More therapies…

    Learn about Your Condition

    Myasthenia gravis Orthostatic hypotension Diabetic nephropathy Lung adenocarcinoma stage IV Schizoaffective disorder Mucopolysaccharidosis II Ulcerative keratitis Large cell lung cancer Ependymoma malignant Dedifferentiated liposarcoma Autoimmune disorder Pleural mesothelioma malignant Pancreatic fistula Nodular melanoma Cervix carcinoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero Universitaria Consorziale Policlinico…

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari

Piazzale Giulio Cesare 11, Bari, 70124, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic gastritis
    Investigated Drugs:
    • Dupilumab
    France Italy Poland

  • Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

    Recruiting

    3 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +8

  • Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Trisomy 21
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    Austria Belgium Czechia Germany Italy The Netherlands +1

  • Comparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    • Dapagliflozin
    • Semaglutide
    Italy

  • Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma After Second-Line Platinum-Based Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma metastatic
    Investigated Drugs:
    • Avelumab
    Italy

  • Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Vindesine Sulfate
    • Inotuzumab Ozogamicin
    • Prednisolone Sodium Succinate
    Austria Czechia Denmark Finland France Germany +5

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DEGLUDEC
    • INSULIN DETEMIR
    • Insulin Glargine
    Germany Italy

  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Prostate cancer
    Investigated Drugs:
    • Copper (64Cu) Chloride
    Italy

  • Study on Treosulfan and Melphalan for High-Risk Ewing Sarcoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Vinorelbine
    • Melphalan
    • Ifosfamide
    Italy

  • Study on the Use of Viscous Budesonide for Children with Eosinophilic Esophagitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Budesonide
    Italy
Previous Page
1 2 3 4 5 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!